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own life, then I, too, must come to know my own story “Dan P. McAdams, 
1993“…  
 
  
Abstract 
Narrative exposure therapy (NET) is considered effective for the treatment of simple PTSD 
(posttraumatic stress disorder) and that from multiple traumas. The efficacy of NET in the 
treatment of child abuse-related PTSD has, to our knowledge, has barely been determined and 
is the objective of this study. Quality of life ratings (QOL) of patients were also determined. 
Using a single-case experimental design, two patients diagnosed with PTSD with the 
Clinician Administered PTSD Scale (CAPS) and having experienced child abuse received 16-
20 sessions of NET. PTSD symptom scores and QOL ratings were obtained weekly following 
sessions using self-report questionnaires. These data and CAPS total symptom severity scores 
were also obtained at the end of treatment and at a 3-month follow-up for Patient 1. Although 
most self-reported data indicated non-significant reductions on total PTSD symptom scores 
and increases in QOL scores, significant reductions were observed for re-experiencing and 
avoidance symptoms for the data of one patient. Reliable change indices (RCIs) from CAPS 
scores indicate clinically significant changes in PTSD symptom scores and QOL ratings for 
both patients at the end of therapy and for the one patient in which these symptoms were 
determined at the 3-month follow-up. Although self-report and clinical results conflict 
somewhat, data from the clinical interview which is superior as a diagnostic tool, indicates 
promising preliminary findings. More research with greater numbers of patients is necessary 
to determine the efficacy of NET as a treatment for PTSD in this patient group.  
  
Inhoud 
Abstract ....................................................................................................................................... . 
1. Introduction ............................................................................................................................ 1 
1.1 “Complex PTSD” ............................................................................................................. 1 
1.2 Treatment of PTSD in patients having experienced child abuse ..................................... 2 
1.3 Narrative exposure therapy .............................................................................................. 5 
1.4 Single case experimental design ...................................................................................... 7 
1.5 Research question and hypotheses ................................................................................... 8 
2. Methods .................................................................................................................................. 9 
2.1 Participants ....................................................................................................................... 9 
2.2 Measures ........................................................................................................................... 9 
2.2.1 Mini-International Neuropsychiatric Interview Plus 5.0 ........................................... 9 
2.2.2 Clinician Administered PTSD Scale ....................................................................... 10 
2.2.3 PTSD Symptom Scale-Self-Report ......................................................................... 10 
2.2.4 Manchester verkorte Kwaliteit van Leven meting .................................................. 11 
2.2.5 Childhood Trauma Questionnaire–Short Form ....................................................... 11 
2.2.6 Exit questionnaire .................................................................................................... 12 
2.3 Procedure ........................................................................................................................ 12 
2.3.1 Design, recruitment of participants and data collection prior to the start of therapy
 .......................................................................................................................................... 12 
2.3.2 Narrative exposure therapy ..................................................................................... 13 
2.3.3 Data collection between therapy sessions, at the end of therapy and at the 3-month 
follow-up .......................................................................................................................... 13 
2.3.4 Data analysis ........................................................................................................... 14 
3. Results .................................................................................................................................. 15 
3.1. Demographic data and case descriptions of patients ..................................................... 15 
3.2. Plots of PTSD symptom scores and QOL ratings ......................................................... 17 
3.3 SPSS mixed models analyses ......................................................................................... 19 
3.4 Reliable change index .................................................................................................... 23 
3.5 CAPS total severity scores ............................................................................................. 24 
3.6 Exit questionnaire ........................................................................................................... 25 
4. Discussion ............................................................................................................................ 26 
4.1. Self-report data .............................................................................................................. 26 
4.2 Clinical interview data.................................................................................................... 28 
4.3 Comparison of the findings from the clinical interview and the self-report data........... 29 
4.4 Improvements in symptoms during the 3-month follow-up ........................................... 30 
4.5 The importance of the results of this study .................................................................... 30 
4.6 Limitations and future research ...................................................................................... 32 
5. Conclusions .......................................................................................................................... 33 
6. References ............................................................................................................................ 34 
Appendix 1 ............................................................................................................................... 40 
Appendix 2 ............................................................................................................................... 41 
Appendix 3 ............................................................................................................................... 42 
Appendix 4 ............................................................................................................................... 45 
Appendix 5 ............................................................................................................................... 47 
 
  
 1 
1. Introduction 
Posttraumatic stress disorder (PTSD) commonly develops following traumatic events, such as 
the threat of or exposure to death, serious injury or sexual violence. Symptoms of this disorder 
include painful recurring memories and dreams of the traumatic event, avoidance of stimuli 
associated with the event and increased arousal. Another important symptom of PTSD is the 
development of adverse changes in mood and cognitions following the trauma (APA, 2014). 
PTSD is a chronic mental health disorder with a lifetime prevalence of 10.4% for women and 
5.0% for men (Breslau et al., 1997). An overall prevalence of 1.1-2.9% was reported for 
PTSD in the EU in 2011 (Wittchen et al., 2011). Approximately 80% of those diagnosed with 
PTSD have a comorbid psychiatric diagnosis, the most frequent of which include depression, 
substance abuse, other anxiety disorders, personality disorders, and psychotic disorders (Van 
Minnen et al., 2015). PTSD sufferers also frequently experience problems with their physical 
health, work and social functioning (Wittchen et al., 2011). 
 
Although the focus of this study is to treat PTSD arising from child abuse, many adults who 
experience abuse during childhood (also) develop a more complex form of PTSD, that of 
“complex PTSD” (Herman, 1992). A discussion of “complex PTSD” is thus warranted here. 
 
1.1 “Complex PTSD” 
The presentation of a more complex form of PTSD in the 1980’s, has led to the proposal of 
the theory of “complex PTSD” (Herman, 1992). “Complex PTSD”, also referred to as PTSD 
with associated features (APA, 2000), often occurs following exposure to complex traumatic 
experiences i.e. those which are prolonged or repeated in nature (Herman, 1992). Child abuse-
related “complex PTSD” can develop from situations involving sexual, physical or emotional 
child abuse whereby victims are exposed for a longer period to repeated occurrences or to 
several forms of trauma. These situations are customarily of an interpersonal nature and under 
circumstances where the victim, the child, is unable to leave due to a variety of restraints, 
namely those of a physical, social, psychological or maturational nature (Herman, 1992 
Cloitre et al., 2012). Abuse occurring in childhood is especially devastating since it occurs 
during those formative years in which the child develops his/her identity along with his/her 
ability to regulate emotions (Stovall-McClough & Cloitre, 2006).  Experiencing child abuse 
has also been shown to have many adverse effects on a child’s mental health.  Furthermore, 
the detrimental effects of child abuse on the attachment style of children have been well 
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established (Stovall-McClough & Cloitre, 2006). Having a history of childhood trauma 
continues to affect the developing brain of teenagers and young adults, particularly affecting 
right brain functions such as mood regulation and social adjustment (Straussner, & Calnan, 
2014). Additionally, in an influential study of adverse childhood experiences, Felitti et al. 
(1998) reported a correlation between childhood abuse and various adult health, behaviour, 
and mental health related problems. A so-called “building block” effect exists with respect to 
PTSD, whereby a relationship exists between the amount of trauma experienced in childhood 
and the degree of pathology in adults (Weber et al., 2008). Individuals having experienced 
such abuse as children have mental health problems beyond those forming the criteria for a 
classic PTSD diagnosis. Indeed, the symptomology seems to be more complicated, more 
extensive and more persistent than simple PTSD (Herman, 1992). It is widely believed that 
individuals suffering from child abuse-related “complex PTSD” also have characterological 
difficulties in at least three domains, namely their (negative) self-concept, in the processing of 
emotions and in relationships (Herman, 1992; Cloitre et al., 2011; Ford, 2015). The far-
reaching consequences of trauma for this group are thus indisputable. 
 
Despite the severity of “complex PTSD”, this disorder is not a specific diagnosis in even the 
most recent version of the DSM, the DSM-5 (APA, 2014). Indeed, there is much deliberation 
over the symptoms of child abuse-related “complex PTSD”. The World Health Organization 
indicated that “complex PTSD” should be classified as separate from PTSD (Maercker et al., 
2013) and in the most recent version of the International Classification of Diseases (ICD-11) 
“complex PTSD” is a separate diagnosis. A more detailed discussion of the specific 
symptoms of child abuse-related “complex PTSD” is outside the scope of this thesis but is 
given by Dorrepaal et al. (2012a) and ter Heide et al. (2014).  
 
1.2 Treatment of PTSD in patients having experienced child abuse 
This lack of a clear characterization of child abuse-related complex PTSD has probably also 
influenced the treatment of this disorder. Evidenced-based imaginary exposure treatments for 
the treatment of simple PTSD include therapies such as (prolonged) exposure, cognitive 
behaviour therapy (CBT) and eye movement desensitization and reprocessing (EMDR; 
Ehlers, 2010). These traditional (exposure-based) interventions for PTSD are also generally 
applied in the treatment of PTSD in adult survivors of child abuse (Ehring et al., 2014). 
However, there is much controversy regarding the efficacy of traditional PTSD treatments for 
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the treatment of PTSD in this patient group. Bradley et al. (2005) report that it is unknown if 
these traditional PTSD  treatments  are the most effective for patients that have histories of 
multiple trauma since the focus of the exposure may not be  as clear and also the influence of 
personality is likely to be greater. Cloitre et al. (2009, 2011) also propose that child abuse-
related PTSD may not respond in the best way to traditional PTSD treatments, taking into 
account the prolonged and repeated nature of the trauma. Keller et al. (2010) suggest that 
patients having a history of complex trauma, such as in the case of childhood sexual abuse, 
may be distrusting of others and may have negative assumptions about social relationships.  
This may obstruct the formation of the therapeutic alliance, which has been shown to be an 
important mediator in therapy (Doukas et al., 2014). Finally, Thomaes et al. (2015) suggest 
that traditional PTSD therapies should no longer be used for the treatment of PTSD in PTSD 
arising from child abuse patients, since scientific evidence for this generalisation is lacking. 
 
In a meta-analysis of therapies for the treatment of PTSD in adults having earlier experienced 
child abuse, Ehring et al. (2014) reported that traditional interventions for PTSD are effective, 
having moderate to high effect sizes. These authors also reported that exposure-based 
therapies were more effective than those not involving exposure. Hedges’s g effect sizes for 
active treatments versus waiting list controls for trauma-focused CBT and EMDR were 0.88 
and 0.76, respectively, compared to that of 0.48 for the non-trauma-focused CBT.  
 
One further topic of debate in the treatment of “complex PTSD” concerns the need for multi-
phased, multi-component therapies. Some authors propose the necessity of a stabilisation 
phase of treatment prior to the processing of the trauma (Cloitre et al., 2002, 2010; Dorrepaal 
et al., 2012b; Ford et al., 2015), the aim of which is to increase the patient’s ability to regulate 
emotions and also to help create a working alliance.  In a randomized controlled trial (RCT) 
women with “complex PTSD” arising from child abuse, received skills training in affect and 
interpersonal regulation (STAIR) prior to exposure treatment  or supportive counselling prior 
to exposure (Support/Exposure) or STAIR followed by  supportive counselling 
(STAIR/Support; Cloitre et al., 2010). These authors reported that the STAIR/Exposure was 
more effective in achieving complete and long-term remission from PTSD symptoms than 
either of the other treatments. Furthermore, the greatest improvements in interpersonal 
relations and in regulation of emotions were achieved by the STAIR/ Exposure treatment. 
However, the methodology proposed in this study has been widely criticised. Cloitre (2015) 
compared the effect sizes from the studies included in the research of Ehring et al. (2014). 
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From the 8 studies involving trauma-based CBT, they observed greater effect sizes in 3 of the 
4 phased, multi-component treatments than for the 4 utilizing exclusively trauma methods. 
This indicates a superiority of the multi-component treatments treatment of PTSD in adults 
having earlier experienced child abuse. However, findings of Dorrepaal et al. (2012b) 
concerning stabilization treatment were equivocal. These authors carried out an RTC 
comparing a treatment as usual (TAU) not involving exposure or following a protocol but 
tailored for the specific needs of the patients to that utilizing TAU and a stabilizing group 
treatment (psychoeducation and CBT). Both treatments resulted in significant decreases in 
both PTSD and “complex PTSD” symptoms with medium and large effect sizes respectively, 
for the control and experimental treatments. However, the use of stabilizing group treatment 
did not lead to significantly greater improvements in either PTSD or “complex PTSD” 
outcomes than the control treatment. Rates of responders (those with a post therapy score on 
PTSD or “complex PTSD” symptoms of 1 standard deviation less than their pre-therapy 
score) were also determined for both groups. With respect to the PTSD symptoms, 
significantly greater rates of responders were observed for the experimental group. This was 
not observed for “complex PTSD” symptoms. Differences also exist with respect to 
continental recommendations for treatment. The International Society for Traumatic Stress 
Studies Complex Trauma Task Force in America proposes a phased treatment for “complex 
PTSD” (Cloitre et al., 2011). This should involve psychosocial stabilization phase followed 
by a phase wherein the traumatic experiences are processed and lastly a phase of psychosocial 
reintegration.  However, Dutch guidelines for the treatment of PTSD advise the trauma-
focused cognitive behavior therapy or EMDR with psychoeducation and exposure (Van 
Balkom et al., 2013). It is important to note, however, that the treatment proposed by the 
American task force was derived from expert opinions while that of the Dutch guidelines is 
evidence-based. 
 
Because of the existence of rather opposing beliefs and findings as to the efficacy of 
traditional and multi-phased, multi-component PTSD therapies for the treatment of complex 
PTSD arising from child abuse, Ford (2015) proposed a need for the development of new 
treatments.  Furthermore, recent PTSD theories suggest that habitation of emotions according 
to the emotional processing theory of PTSD, to which exposure therapy is associated, is only 
one method to reduce PTSD symptoms (Neuner et al., 2004). In their cognitive model of 
PTSD, Ehlers and Clark (2000) propose that disturbed functioning of the autobiographical 
memory as portrayed by inadequate elaboration and contextualisation together with good 
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associative memory and good perceptual priming, contributes to the persistence of the sense 
of threat associated with the trauma. The natural narrative processing of one’s daily life 
experiences is thus believed to be disturbed in traumatized individuals. According to Wigren 
(1994), such incomplete narrative processing of the trauma memories results in PTSD 
symptoms. The reconstruction of the trauma memories and their integration into the 
individual’s life story in the form of a narrative is thus required to reduce re-experiencing. 
Furthermore, the third of the recent models of PTSD, the dual representation model proposes 
that trauma memories are dissociated from the regular system of memory (Brewin, 2001) and 
that recovery requires their conversion to regular, narrative memories (Brewin & Holmes, 
2003). 
 
Thus, a treatment integrating both exposure and narrative therapy as in the case of narrative 
exposure therapy (Schaeur et al., 2005) appears suitable to treat PTSD symptoms since it 
seems to incorporate at least a part of, all 3 of the recent psychological theories of PTSD.  
 
1.3 Narrative exposure therapy  
Narrative exposure therapy (NET) is a recent variation of the traditional trauma-focused 
cognitive behaviour therapy (CBT) for the treatment of PTSD. NET involves both exposure to 
the traumatic events and the chronological organization of these memories into a personal 
narrative (Schauer et al., 2005). NET was developed by Schauer et al. (2005) with the 
intention of being a short-term, standardized treatment which could be effective irrespective 
of culture and which can be provided by local psychologists or even lay people. An important 
aim of NET is to increase encoding of explicit memories through activation of anxiety-
evoking memories so that they can be stored. In this way, the time the event occurred is 
anchored, thereby allowing the present sense of threat to be diminished (Robjant & Fazel, 
2010).   
 
NET has already been shown to be effective for the treatment of patients of PTSD of diverse 
cultural backgrounds with multiple traumas namely refugees, soldier veterans and others 
suffering from trauma (Jongedijk, 2014). In a review of 9 studies concerning the efficacy of 
NET in the treatment of PTSD in refugees, asylum seeker and orphans, Robjant and Fazel 
(2010) reported that NET was more efficient than the other therapies (supportive counselling, 
psychoeducation or group interpersonal therapy) in the reduction of PTSD symptoms. Many 
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of the studies also showed that these positive outcomes were maintained at 6-12 months 
follow-up. However, some studies did not compare NET with the current standard treatment. 
Furthermore, the power of some studies to show the efficacy is limited since samples sizes 
varied from 6 to 111. In a meta-analysis of 7 quantitative studies, Gwozdziewycz and Mehl-
Madrona (2013) found a medium effect size (0.63) for NET for refugees with trauma or 
PTSD. Furthermore, in a review comparing prolonged exposure therapy with NET, Mørkved 
et al. (2014) proposed that NET may be advantageous over prolonged exposure therapy in the 
treatment of victims of multiple traumas such as in the case of asylum seekers and refugees. 
This arises from the suggestion of Palic and Elklit (2011) that exposure treatments aimed for 
single traumas may not be suitable for the treatment of PTSD in patients having experienced 
multiple traumatic experiences, as may be the case in refugees. Furthermore, NET is designed 
particularly for patients that have experienced multiple traumas and takes the context of the 
trauma into account (Schauer et al., 2005). Jongedijk (2014) remarked that in a number of 
studies, the positive effects on PTSD symptoms from NET were still observed in the follow 
up measurements at least 6 months after the end of therapy. Furthermore, even greater 
reductions in PTSD symptoms could often be seen after the end of therapy. Besides being 
shown to be effective for the treatment of refugees with multiple traumas, NET also appears 
very suitable for the treatment of other patients suffering from multiple traumas (Jongedijk, 
2014). 
 
Preliminary results from two open studies using NET with patients of PTSD from childhood 
trauma also seem positive (Jongedijk, 2014). In one such study, Pabst et al. (2012) 
investigated the efficacy of NET for the treatment of 10 adult patients with borderline 
personality disorder (BPD) with a comorbid PTSD diagnosis, whose symptoms were deemed 
very severe. Large pre-treatment to 6 month post-treatment Hedges’s g effect sizes of 0.92 
and 0.85 were observed for PTSD symptoms and depression respectively. Large effect sizes, 
of ~0.85 for both BPD symptoms and dissociation symptoms were also observed (Pabst et al., 
2012). A second open study using NET was carried out in Japan on five adults with child 
abuse-related complex PTSD (Dōmen et al., 2012, as cited in Jongedijk, 2014). Although 
there was no significant reduction in depressive symptoms, significant improvements were 
observed for PTSD symptoms, dissociation, feelings of guilt, relationships and functioning in 
society. The quality of this study is, however, difficult to determine since it was published in 
Japanese. 
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Although these initial results on the efficacy of NET on “complex PTSD” seem promising, 
they need to be confirmed in controlled studies with much greater numbers of patients. The 
present study therefore investigates the efficacy of NET in the treatment of PTSD symptoms 
arising from child abuse. In this study, a single-case experimental design was chosen to allow 
the efficacy of NET to be established while also providing the opportunity for elements of the 
mechanism of NET to be studied.   
 
1.4 Single case experimental design  
For more than a century, psychotherapy has been formally used for the treatment of 
psychological problems. Although much evidence exists for the efficacy of therapy, a lot 
remains to be learned, e.g., which treatments are the most effective for the particular disorders 
(Strauman et al., 2013). Also, evidence as to how even the most well-studied therapies work is 
greatly lacking (Kazdin, 2007). This is especially true for newer treatments such as NET.  
 
RCTs are considered the golden standard in research for evaluating the effectiveness of 
therapies. By comparing the outcomes of an experimental therapy group with those from a 
control group, the effectiveness of the therapy can be determined. Unfortunately, however, 
RCTs provide little information as to why a particular therapy is effective (Versluis et al., 
2014).  Single-case experiments, or N = 1 experimental designs, are an alternative type of 
study design involve frequent measurement of therapy outcomes for individual patients over 
the course of the therapy. In these designs, each patient is his or her own control allowing a 
within-subject comparison (Smith, 2012). Single-case experiments date back to the beginning 
of the 20
th
 century. Indeed, the infamous psychological studies of Watson (1925) and Skinner 
(1938) both involved single-case experiments (Smith, 2012). Although these study designs 
have been relatively little used in past decades, single-case experiments have regained 
popularity in recent years. This is probably at least partly due the great contributions which 
were made to our understanding of behaviour using these designs.  
 
Single-case designs consist of at least two experimental phases, a baseline phase prior to 
therapy and therapy phase. Data concerning the therapy outcomes is collected during the 
baseline phase and is compared with data collected following the individual therapy sessions. 
Any reduction in symptoms over this period is deemed to be associated with the therapy. 
Indeed, the main aim of single-case experimental designs is to determine whether an 
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independent variable provided by the researcher (e.g., therapy) is associated with a change in 
the dependent variable (e.g., the symptoms of the disorder; Smith, 2012). An important 
advantage of single-case experimental designs is that through such frequent measurements, 
they provide more detailed information concerning the progress of the individual patients 
(Versluis et al., 2014).  These designs also provide therapists and researchers the opportunity 
to report their observations and they thus allow the gathering of relevant information to be 
maximized and compared for different patients (Kazdin, 2008). This detailed information can 
help determine which particular techniques or components of the therapy make it effective, 
i.e., the mechanism. In the current study therefore, we employ a single-case experimental 
design.  
 
We used an internet-based program as a means of collecting data in this study. With the 
internet being currently used globally for a huge variety of services in daily life, it is logically 
also becoming more popular as a research tool. Using an internet-based program to collect 
data in this study also has several advantages over the traditional use of paper questionnaires. 
Firstly, it provides more privacy and flexibility since the patient has the choice of where, 
when and how long he/she takes to answer the questions. Furthermore, it allows greater 
anonymity in the collection of data since patients receive emails from a software program. 
Both of these advantages may aid in the patient answering the questions more honestly, which 
is important for the reliability of the research findings. 
 
1.5 Research question and hypotheses 
The research question for this study involves establishing if narrative exposure therapy (NET) 
can provide a reduction of PTSD symptoms and an increase in quality of life (QOL) ratings of 
patients with child abuse-related PTSD.  
 
The hypotheses for this study are: 
1. There is a correlation between the amounts of NET a patient receives and the 
reduction PTSD symptom scores in patients (hypothesis 1a). A correlation also exists 
between the amount of NET received and an increase in QOL ratings (hypothesis 1b). 
2. PTSD symptom scores are significantly less at the end of the treatment phase as 
compared to at the baseline phase (hypothesis 2a). QOL ratings are significantly 
greater at the end of treatment relative to at the baseline (hypothesis 2b). 
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3. The effects of NET on the reduction of PTSD symptom scores in patients are 
clinically significant (hypothesis 3a). The effects of NET on the increase in QOL 
ratings are also clinically significant (hypothesis 3b) 
 
In the case of NET, improvements in symptoms often continue to occur several months 
following the end of therapy. To avoid having too large a number of hypotheses, however it 
was decided to base hypotheses in this thesis only on the period between the start and the end 
of therapy. Improvements at the 3-month follow up will also be discussed though since they 
are obviously relevant for the treatment outcomes.   
 
2. Methods 
 
2.1 Participants 
Patients (N=2) diagnosed with PTSD arising from child abuse were recruited from the waiting 
list for PTSD treatment at PsyQ Den Haag Noord. These patients were further assessed for 
their suitability to take part in this study using the following inclusion criteria, 1) being 
traumatized before 16 years of age, 2) being able to speak Dutch and 3) being considered 
suitable for exposure treatment by the clinics’ intake staff. Exclusion criteria for this study 
included having current psychoses or serious depression with suicidality or alcohol or drug 
misuse or dependence. Furthermore, medication use had to be stable in the month prior to the 
therapy and patients should not have auto-mutilated for which medical treatment was 
necessary within 2 months, as determined by the Mini-International Neuropsychiatric 
Interview Plus 5.0 (MINI; Sheehan et al., 1998).  
 
 
2.2 Measures 
2.2.1 Mini-International Neuropsychiatric Interview Plus 5.0  
The Mini-International Neuropsychiatric Interview Plus version 5.0 (MINI) is a structured 
interview used in the initial baseline assessment of patients for psychiatric disorders. It allows 
a concise screening for the most important disorders of Axis 1 of the DSM-IV including 
addictions. With respect to the validity, sensitivities and specificities have been calculated. 
For all diagnoses except for those of generalized anxiety disorder, bulimia and agoraphobia 
these measures are either good or very good (Lecrubier et al., 1997). Also for all diagnoses 
the inter-rater reliability is very good with kappa coefficients of 0.88-1.0 for 42 patients 
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(Lecrubier et al., 1997). Test-retest reliability for 23 diagnoses with the MINI is also very 
good with kappa values for 19 of the diagnoses ranging between 0.65 and 1.0 and with only 1 
being below 0.40 (Sheehan et al., 1998).  
 
2.2.2 Clinician Administered PTSD Scale  
PTSD was diagnosed using the Dutch version of the Clinician Administered PTSD Scale 
version IV (CAPS; Blake et al., 1990 and the Dutch translation, Hovens et al., 2005) which is 
a standard measure for the assessment of PTSD internationally. The CAPS is a semi-
structured clinical interview consisting of 30 items corresponding to the criteria for PTSD 
according to the DSM-IV (APA, 2014). It measures the 17 symptoms of PTSD and 
incorporates an ordinal scale comprising of 5 points to measure the intensity and frequency of 
each symptom. In a review of the first 10 years of research using the CAPS, Weathers et al. 
(2001) reports of the excellent psychometric properties that the CAPS possesses in a variety 
of trauma populations. This instrument has excellent inter-rater reliability with reliability 
coefficients (r) of 0.92-0.99, being obtained for frequency and intensity scores across the 3 
main clusters of symptoms. Also, the internal consistency is high across these three clusters of 
symptoms with alpha coefficients of 0.73-0.85 (Weathers et al., 2001). There is also great 
evidence of validity with correlations for convergent validity with several self-report 
instruments for measuring PTSD (Impact of Event Scale, The PTSD Checklist, The 
Mississippi Scale for Combat-Related PTSD, The Davidson Trauma Scale and The Keane 
PTSD Scale) ranging from 0.70-0.90. In this study the CAPS was used for two purposes; 1) as 
a diagnostic tool to determine if patients met the criteria for PTSD and 2) as a measure of the 
total PTSD symptoms severity scores for patient prior to and following their treatment. For 
the purpose of diagnosis, symptoms for which a frequency score of 0 or 1 was obtained were 
not included while they were included for the total symptom severity scores.  
  
2.2.3 PTSD Symptom Scale-Self-Report  
The Dutch version of the PTSD Symptom Scale-Self-Report (PSS-SR; Foa et al., 1993 and 
Dutch translation, Arntz, 1993) as shown in Appendix 2, was used to determine the PTSD 
symptom scores and to establish the degree of disruption of the patient’s life due to these 
symptoms. This questionnaire was administered prior to therapy (baseline), as an outcome 
measure following the weekly therapy sessions and at the 3-month follow up. The PSS-SR is 
a self-report measure with 17 items and higher scores indicate a greater number of PTSD 
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symptoms. It has a satisfactory internal consistency with a Cronbach’s alpha for the total 
score of the PSS-SR of 0.91 (Foa et al., 1993). For the subscales of re-experiencing, 
avoidance and arousal, alpha coefficients of between 0.78-0.82 were observed. The one-
month test-retest reliability of the total score of the PSS-SR was high with a Pearson’s 
correlation of 0.74. The concurrent validity is also good with Pearson correlation coefficients 
relating PSS-SR total scores to other measures of psychopathology all being significant at 
p<0.5.  Furthermore, the convergent validity of the PSS-SR as determined by comparing 
diagnoses of PTSD with those from SCID interviews was good with a kappa of 0.68 (Foa et 
al., 1993). The psychometric properties of the Dutch translation of the PSS-SR are also 
considered good (Engelhard et al., 2007). 
 
2.2.4 Manchester verkorte Kwaliteit van Leven meting  
The Manchester verkorte Kwaliteit van Leven meting (MANSA VN-12; Van Nieuwenhuizen 
et al., 2015), as shown in Appendix 3, was used to determine the satisfaction of life prior to 
the study (baseline), following treatment sessions and at the 3-month follow up. The question 
concerning the sex life of the patient was omitted since it was considered too confronting for 
the patients by an experienced researcher in this area. The MANSA VN-12 is a self-report 
inventory whereby higher scores represent a greater QOL. The MANSA VN-12 has 
satisfactory psychometric properties including correlation coefficients between satisfaction 
scores of >0.83 and a Cronbach’s alpha for QOL ratings of 0.74 (Priebe et al., 1999).  
 
2.2.5 Childhood Trauma Questionnaire–Short Form  
The Dutch version of the Childhood Trauma Questionnaire–Short Form (CTQ–SF; Bernstein 
et al., 2003), as shown in Appendix 4,  was used to gather background information on the type 
of trauma that patients experienced during childhood. It is a retrospective self-report measure 
consisting of 28 items, of which 25 are clinical and 3 are validity items. The CTQ–SF covers 
five domains of maltreatment; emotional, physical and sexual abuse and emotional and 
physical neglect.  (Scher et al., 2001). Five items cover each sort of maltreatment providing 
sufficient reliability and covering the content. Each item is scored on a Likert-type scale 
whereby responses can vary from 1, for never true, to 5, for very often true. Satisfactory 
psychometric properties for the CTQ–SF have been demonstrated including test–retest 
reliability (Bernstein & Fink, 1998) and the internal consistency of the Dutch version of this 
questionnaire (Thombs et al., 2009).These authors reported Cronbach's alpha’s for physical, 
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emotional and sexual abuse and for emotional neglect of 0.91-0.95 along with 0.63 for 
physical neglect. Furthermore, the convergent validity between scores from Dutch patients 
and responses on the ITEC, an interview for traumatic events in childhood on all 5 CTQ-SF 
scales were good. (Lobbestael et al., 2009). 
 
2.2.6 Exit questionnaire  
A questionnaire developed at PsyQ (see Appendix 5) was developed to get the opinion of the 
patients on their expectations of narrative exposure therapy, the effect of the therapy on their 
symptoms and their views on the therapy. Patients filled in this questionnaire at the end of the 
therapy. 
  
2.3 Procedure 
2.3.1 Design, recruitment of participants and data collection prior to the start of therapy 
A single-case experimental AB, design (Barlow & Hersen, 1973) was utilized in this study. In 
addition to having a diagnosis of PTSD due to childhood trauma, patients had to satisfy the 
inclusion and exclusion criteria. Patients deemed suitable were contacted by telephone by 
their proposed therapists to explain the research and to invite them to participate. Patients 
expressing interest were then sent detailed information about NET and those agreeing to 
participate were subsequently telephoned to arrange appointments for the baseline 
measurements. During this appointment, the MINI and CAPS interviews were carried out by a 
trained psychologist to definitely ascertain suitability of the patient for the study regarding 
DSM-IV diagnoses generally, and the specific diagnosis of PTSD. This psychologist was not 
involved in the research in any other way. At this time, patients also gave demographic data 
and filled in de PSS-SR and the MANSA VN-12 to provide baseline data. Following the 
proposal of Blake et al. (1990) that a total PTSD symptom severity score of >65 on the CAPS 
indicates a diagnosis of severe PTSD, only participants having this initial score were included 
in this research. IncludedPatients also filled in the CTQ-SF questionnaire to provide 
background data for the nature of the childhood trauma. Furthermore, patients provided 
written consent to participate in the research. NET sessions began within a week. Five 
measures of baseline data were gathered, whereby patients completed the PSS-SR and 
MANSA VN-12 questionnaires over a period of approximately 2 weeks. Vacation periods of 
the therapist or other natural breaks in the therapy were used as additional baseline phases in 
which patients also completed the PSS-SR and MANSA VN-12 questionnaires. Follow-up 
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measurements at 3 months after the end of therapy were taken for Patient 1, but due to the 
time scale for this thesis, will only be taken at a later stage for Patient 2. Follow-up data for 
Patient 2 are therefore not included in this thesis.  
This research was approved by the Research Committee of PsyQ Den Haag Noord. 
 
2.3.2 Narrative exposure therapy  
NET was carried out in individual sessions in Dutch by two psychotherapists trained to work 
with this form of therapy. NET was performed according to the method of Schauer et al. 
(2005). Briefly, NET initially involved creating the lifeline of the patient using a small rope, 
flowers and stones. The stones and flowers were used to represent traumatic events and 
positive events, respectively. The traumatic and positive events of the lifeline were then 
discussed in chronological order. Both traumatic and positive events, but particularly 
traumatic events, were worked through using exposure therapy. This involved the 
simultaneous activation of the anxiety network associated with the trauma and the context 
information of the traumatic event. A report of the content represented by particularly the 
traumatic events, but also of the positive events as discussed in each session, was prepared. 
This report was read aloud to the patient at the beginning of the following session. Finally, at 
the end of the treatment, the patient received a shortened version of the combined session 
reports, as proposed by Schauer et al. (2005). An assistant researcher was present during the 
sessions to write the therapy report. The assistant was in no other way involved in the therapy. 
Sessions lasted approximately 90 minutes and were carried out weekly to treat all traumatic 
experiences for a maximum of 20 sessions.  
 
2.3.3 Data collection between therapy sessions, at the end of therapy and at the 3-month 
follow-up 
The PSS-SR and MANSA VN-12 questionnaires were put together to comprise a survey 
using the Qualtrics Research Suite 2015 software (Qualtrics Labs Inc., Provo, UT, USA). 
Four days after each therapy session and before the following therapy session, links to the 
survey were e-mailed via the Qualtrics program to participants. If the survey was not filled in 
1 day after receiving the questionnaire, patients were sent a first reminder. If the survey was 
still not filled in 2 days after receiving the questionnaire, a second reminder was sent. If the 
survey was still not filled in after 2 reminders, no further action was taken and data were 
considered missing for that time point. At the end of therapy patients underwent a second 
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CAPS interview as well as completing the exit questionnaire. Three months following the end 
of therapy patients filled in the PSS-SR and the MANSA VN-12 questionnaires via Qualtrics 
and Patient 1 underwent a third CAPS interview. The same psychologist performed all CAPS 
interviews as well as giving assistance with the completion of the exit questionnaire. 
2.3.4 Data analysis 
Demographic data and case descriptions 
Demographic data obtained from patients, diagnoses made with the MINI and the CAPS at 
the screening appointment prior to starting therapy and background information obtained from 
the patient database at the institution were put together to comprise case descriptions.  
 
Visual inspection of plots of PTSD symptom scores and QOL ratings  
Graphs showing PTSD symptom scores and ratings for the QOL for the individual clients 
prior to and following weekly treatment were prepared and visually examined as a way of 
determining the efficacy of NET. These graphs were used to determine if there was a 
correlation between the amount of NET received and the reduction in PTSD symptom scores 
in patients (hypothesis 1a). Also, the existence of a relationship between the amount of NET 
and an increase in QOL ratings was established (hypothesis 1b). 
 
SPSS mixed models analysis  
Although data of single subjects can be analysed by statistical techniques using either 
parametric or non-parametric methods, these methods are difficult to apply (Maric et al. 
2015). In this research, the SPSS method of Maric et al. (2015) developed to analyse 
univariate data was therefore used to determine the significance with respect to changes in 
symptoms with NET. This method is illustrated in the following video: 
http://youtu.be/sYGOynx-J8M.  With this mixed models analysis, we established if PTSD 
symptom scores were significantly less at the end of the treatment phase as compared to at the 
baseline phase (hypothesis 2a). Similarly, the significance of the increases in QOL ratings at 
the end of treatment relative to at the baseline were determined (hypothesis 2b). 
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Reliable change index  
The clinical meaningfulness of any effects of NET observed in this research was determined 
using the reliable change index (RCI) described by Jacobson and Truax (1991). This was 
carried out by comparing PTSD symptom scores measured at the baseline with those at the 
end of the therapy and establishing if any reductions in symptoms were clinically significant 
(hypothesis 3a). RCIs with respect to changes in PTSD symptom scores were measured with 
data from both the PSS-SR and the CAPS, the latter in the form of CAPS total severity scores 
The RCI analysis was applied to determine the clinical significance of increases in QOL 
ratings at the end of therapy relative to at the baseline (hypothesis 3b). For this analysis data 
from the MANSA VN-12 was used. 
 
3. Results 
3.1. Demographic data and case descriptions of patients 
Demographic data, the type of child abuse experienced and diagnoses according to the MINI 
and CAPS PTSD diagnoses of the two patients involved in this study are given in Table 1. 
This data is further discussed in the case descriptions below. 
 
Patient 1 was a 44 year-old married Argentinian mother of 5 children. She went to Germany 
with a friend in her early twenties, where she was forced to work as a prostitute before 
escaping to the Netherlands in 1997. She currently lives with her present husband, their two 
children, age 4 and 12, and her sick mother-in-law. She is educated to university level. She 
has been unemployed for almost a year, since losing her job because of her psychological and 
health problems.  As a child, she suffered extreme emotional abuse and emotional neglect, as 
well as severe to extreme physical abuse and physical neglect. Her parents separated at age 5 
and her and her two brothers were brought up by her grandparents and father. At age 19, she 
began to experience depressive symptoms and has since had 10 depressive episodes, including 
the current episode. She also has a current diagnosis of dysthymia. Prior to the age of 30, she 
has had many somatic symptoms, including head, stomach and back pain. She also suffers 
from fibromyalgia and thyroid problems. These problems have lasted for many years and 
have had an important effect on her functioning in important areas of her life, including her 
work. An organic cause has not been ruled out.  She has made 2 suicide attempts. In the 
month prior to the PTSD therapy, she was considered a moderate suicide risk. She has had 
treatment for depression prior to being included in this study. In the past, she has been 
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dependant on Valium and sleeping pills, but she is not currently dependant on these 
medicines. Prior to the therapy she was diagnosed with PTSD. 
Table 1. Demographic data of patients, type of child abuse experienced by patients, Mini-
International Neuropsychiatric Interview Plus 5.0 (MINI) diagnoses and PTSD diagnoses 
before and after therapy as determined by the Clinician Administered PTSD Scale (CAPS).  
 Patient 1 Patient 2 
Demographic data  
Age (years) 
 
44 
 
35 
Gender Female Female 
Highest education level University Higher professional education 
Marital status Married Single 
Ethnicity Argentinian Dutch 
   
Type of child abuse   
Emotional abuse Severe to extreme Severe to extreme 
Emotional neglect Severe to extreme Severe to extreme 
Physical abuse Severe to extreme Low to moderate 
Physical neglect Severe to extreme Severe to extreme 
Sexual abuse None to minimal Severe to extreme 
   
Diagnoses (MINI)   
PTSD diagnosis Yes Yes 
Number of additional  diagnoses   
-lifetime 4 2 
-current 3 2 
   
PTSD Diagnoses (CAPS)    
PTSD before therapy Severe Severe 
PTSD after therapy Moderate Severe 
PTSD 3 mo follow-up  Moderate NA* 
*Data not yet available 
 
 
 
Patient 2 was a 35 year-old single Dutch woman who lives alone. She is educated to HBO 
level and works fulltime in rehabilitation. As a child, she suffered severe to extreme 
emotional abuse and emotional neglect. She also experienced low to moderate physical abuse, 
physical neglect and severe to extreme sexual abuse involving her father. She was an only 
child. Her family moved from Amsterdam to Haarlem when she was 8. Her parents had an 
unhappy marriage and divorced when she was 24. Her father died 2 years later. She had 
problems in intimate relationships and is currently single. In 2015, she experienced a short 
psychotic episode. Stress and possibly cannabis use are believed to be contributing factors in 
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this episode. At the pre-screening stage of this research, she was diagnosed with depression 
(current episode) and considered a low suicide risk. She was also diagnosed with PTSD. 
 
3.2. Plots of PTSD symptom scores and QOL ratings   
Visual plots of PTSD symptom scores and QOL ratings following therapy sessions are shown 
in Figure 1 and Figure 2 for Patient 1 and Patient 2, respectively. Initial baseline PTSD 
symptoms scores of 36 to 41 were observed for Patient 1, which decreased to 34 after the first 
therapy session. Following the 5
th
 NET session, the lowest PTSD symptom score, 31, was 
observed for this patient. Following this session, scores generally increased to a maximum of 
50, with a score of 40 after the last therapy session. At the 3-month follow-up measurement 
PTSD symptom scores had decreased to 33. There appeared to be little reduction in PTSD 
symptom scores at the end of treatment compared to that prior to treatment. Therefore a 
correlation between the amount of NET which Patient 1 received and a reduction in PTSD 
symptom scores is unlikely.  Thus, hypothesis 1a appears to be false for Patient 1. The PTSD 
symptom score at the 3-month follow-up (33), however, was one of the lowest scores 
observed. Baseline QOL ratings ranged from 29-33 for Patient 1 and remained around this 
value for the rest of the therapy apart from one very low value of 19 following the therapy 
session in week 10. Increases in QOL ratings were usually observed with decreases in PTSD 
symptom scores and vice-versa. A QOL rating of 33 was observed at the 3-month follow-up. 
With an average baseline value of 31 prior to therapy and a value of 29 at the end of 
treatment, there appeared to be no improvement in the QOL ratings of Patient 1 at the end of 
the treatment compared to that at the beginning. There is therefore also probably no 
correlation between the amount of NET Patient 1 had and an increase in her QOL ratings. 
Hypothesis 1b is therefore also false for Patient 1.  
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Figure 1. Visual plots of PTSD symptom scores and quality of life (QOL) ratings for Patient 1 
prior to and following weekly narrative exposure therapy (NET) sessions.  
 
 
 
Figure 2. Visual plots of PTSD symptom scores and quality of life ratings (QOL) for Patient 2 
prior to and following weekly narrative exposure therapy (NET) sessions.  
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Patient 2 had initial baseline PTSD symptom scores ranging between 42 and 47 (Figure 2), 
which remained rather constant up to the therapy session of week 12. The patient did not fill 
in any data following the therapy session of week 13 and therefore there are no data included 
for this session. From week 14 onwards, scores fluctuated from between 28 and 48 to a final 
score of 30 at the end of therapy. There appears to be only a very slight reduction in PTSD 
symptom scores at the end of treatment compared to that prior to treatment. From the data 
presented in Figure 2, it therefore seems unlikely that there is a correlation between the 
amount of NET which Patient 2 received and a reduction in her PTSD symptom scores.  
Hypothesis 1a therefore seems also false for Patient 2. The baseline QOL ratings for patient 2 
ranged from 39 to 43. Apart from a dramatic drop to 27 after the 1
st
 therapy session, values 
remained fairly constant throughout the treatment period, with a final value of 46 at the end of 
treatment. There does appears not appear to be a correlation between the amount of NET 
received and an increase in QOL ratings. Hypothesis 1b therefore appears to be also false for 
Patient 2.   
 
3.3 SPSS mixed models analyses 
Treatment efficacy results from analysis with SPSS mixed models are outlined in Table 2 and 
Figures 3-6. Analysis of the data of Patient 1 could not be carried out since only 3 baseline A 
measurements were taken for Patient 1 and 5 are needed for this analysis.  
 
The parameter b0 (Table 2) represents the baseline score for the groups of symptoms re-
experiencing, arousal and avoidance and QOL factors. Parameter b1 is the difference in these 
symptoms and factors between the end of the baseline and the end of treatment. A negative 
value of b1 indicates a decrease in symptoms. In this study, a negative value for b1 was 
obtained with respect to re-experiencing, arousal and avoidance symptoms (Table 2). A 
positive value for b1 was obtained for QOL ratings, which indicates an increase in QOL at the 
end of the therapy. There was a significant phase difference between baseline and treatment 
phases for re-experiencing and avoidance symptoms with p <0.10 for b1 for both. Hypothesis 
2a, which proposes that PTSD symptom scores are significantly less at the end of the 
treatment phase as compared to at the baseline phase, is thus true for both these symptom 
groups for Patient 2. There were no significant differences, however, with respect to arousal 
symptoms or QOL ratings with p >0.10 for b1 in both cases. Hypothesis 2a is therefore false 
for Patient 2 for arousal symptoms. Hypothesis 2b, that QOL ratings are significantly greater 
at the end of treatment relative to at the baseline is also false for Patient 2.  
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Table 2. Treatment efficacy results at the end of treatment for Patient 2 from SPSS mixed 
models analysis.   
(a) Estimates of fixed effects with re-experiencing as the dependent variable. 
 
Estimate SE p 
90% Confidence Interval 
Lower bound Upper bound 
Intercept (b0) 12.82 0.79 0.000 11.40 14.25 
Phase (b1) -1.74 0.89 0.080 -3.35 0.12 
Time in phase (b2)  0.30 0.35 0.398 -0.32 0.93 
Time in phase*phase (b3) -0.21 0.35 0.555 -0.83 0.41 
     
(b) Estimates of fixed effects
 
with avoidance as the dependent variable. 
 
Estimate SE p 
90% Confidence Interval 
Lower bound Upper bound 
Intercept (b0) 16.74 0.92 0.000 15.08 18.40 
Phase (b1) -3.09 1.04 0.014 -4.96 -1.21 
Time in phase (b2)  -0.25 0.40 0.541 -0.97 0.47 
Time in phase*phase (b3) 0.41 0.40 0.334 -0.32 1.13 
 
(c) Estimates of fixed effects
 
with arousal as the dependent variable. 
 
Estimate SE p 
90% Confidence Interval 
Lower bound Upper bound 
Intercept (b0) 15.37 1.07 0.000 13.31 17.43 
Phase (b1) -2.03 1.26 0.167 -4.55 0.50 
Time in phase (b2)  -0.38 0.44 0.412 -1.20 0.44 
Time in phase*phase (b3) 0.50 0.45 0.302 -0.35 1.34 
      
(d) Estimates of fixed effects
 
with quality of life (QOL) as the dependent variable. 
 
Estimate SE p 
90% Confidence Interval 
Lower bound Upper bound 
Intercept (b0) 39.08 47.25 0.974 -8858765.96 8858835.11 
Phase (b1) 7.00 12.51 0.588 -15.64 29.64 
Time in phase (b2)  0.75 1.63 0.661 -2.43 3.93 
Time in phase*phase (b3) -2.11 1.85 0.307 -5.86 1.64 
 
Parameter b2 is interpreted as the rate of change in the baseline phase and as such values 
should be negligible. Values observed in this study were small with a maximum for QOL 
ratings at 0.75. Parameter b3 is the difference in rates of change with respect to the symptoms 
and ratings between the baseline phase and the NET phase and b3 must be interpreted with b2. 
When b2  is negative and b3 is positive, as is the case for all 3 of the main groups of PTSD 
symptom scores in this study, this indicates a greater decrease in symptom scores during the 
NET phase as compared to the baseline phase. For the QOL ratings, the reverse was seen; i.e., 
b2  was positive and b3  was negative which is indicative of a greater increase in QOL 
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following NET as compared to in the baseline phase. However, neither the decreases in the 
groups of PTSD symptom scores or the increases in QOL ratings were significant with 
(p>0.10) for b2 and b3 in all cases. An α of 0.10 was used for significance in this analysis 
(Maric, 2016).  
 
 
Figure 3. Visual representation of the models of the differences between the baseline and 
narrative exposure therapy (NET) phases on re-experiencing symptoms for Patient 2. 
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Figure 4. Visual representation of the models of the differences between the baseline and 
narrative exposure therapy (NET) phases on avoidance symptoms at the end of therapy for 
Patient 2. 
 
 
 
 
Figure 5. Visual representation of the models of the differences between the baseline and 
narrative exposure therapy (NET) phases on arousal symptoms for Patient 2. 
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Figure 6. Visual representation of the models of the differences between the baseline and 
narrative exposure therapy (NET) phases on quality of life (QOL) ratings for Patient 2. 
 
 
3.4 Reliable change index  
The reliable change index (RCI) was used to determine clinical significance of the changes in 
PTSD symptom scores and QOL ratings from prior to therapy to after therapy and from prior 
to the therapy to the 3-month follow-up. RCIs for PTSD symptom scores, calculated from 
data from both the PSS-SR and the CAPS, and QOL ratings are given in Table 3. The RCI for 
the PTSD symptom scores (PSS-SR) for Patient 1 following NET were 0.28 and -0.84 
respectively for at the end of therapy and at the 3-month follow up (see Appendix 1 for 
calculations). These changes are deemed non-significant however, since according to 
Jacobson and Truax (1991) the RCI must have an absolute value of at least 1.96 for a change 
to be clinically significant. Hypothesis 3a, i.e., that effects of NET on the reduction of PTSD 
symptom scores in patients are clinically significant, is therefore not true with respect to the 
PSS-SR either at the end of treatment or at the 3-month follow-up for Patient 1. The RCI for 
PTSD symptom scores using the PSS-SR for Patient 2 at the end of therapy was at an absolute 
value of 2.0, clinically significant. Hypothesis 3a is therefore true for Patient 2.  
 
With the large range of standard deviations available for the CAPS total symptom scores, and 
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0 
5 
10 
15 
20 
25 
30 
35 
40 
45 
50 
Q
O
L 
ra
ti
n
gs
 
data model 
 24 
value to calculate the RCI. The average of two standard deviations, i.e., that of 14.2 (Morath 
et al., 2014; n=19) and 16.2 (Van den Berg et al. 2015; n=155) was therefore employed in 
these calculations. RCI values for Patient 1 for the changes in PTSD symptom scores as 
determined by the CAPS at the end of therapy and at the 3-month follow-up were -2.07 and -
3.14 respectively. Since both absolute values are greater than 1.96, changes in the CAPS total 
severity scores for Patient 1 during both periods are considered clinically significant. The RCI 
for Patient 2 for the decrease in PTSD symptoms between prior to therapy and at the end of 
therapy at -2.68 also indicates a clinically significant change. Hypothesis 3a is therefore true 
for CAPS values for Patient 1 and Patient 2 at the end of therapy and for Patient 1 at the 3-
month follow-up. Changes in the QOL ratings appear not to be of clinical significance 
however. Patient 1 had CAPS, RCI absolute values of 0.52 for both the changes in PTSD 
symptom scores between prior to therapy and at the end of treatment and between prior to 
therapy and the at the 3-month follow-up. For Patient 2 the RCI for between prior to therapy 
and at the end of treatment was 1.37. Hypothesis 3b, i.e. the effects of NET on the increase in 
QOL ratings are clinically significant, is not true for Patient 1 at either time-point or for 
Patient 2 at the end of therapy.  
 
Table 3. Reliable change indices (RCI) for PTSD symptom scores, quality of life (QOL) 
ratings and CAPS total severity scores of patients at the end of therapy and at the 3-month 
follow-up. 
 PSS-SR CAPS          QOL 
Patient 1     
-End of therapy +0.28 -2.07 -0.52 
-3 mo follow-up -0.84 -3.14 +0.52 
Patient 2    
-End of therapy -2.0 -2.68 +1.37 
-3 mo follow-up    NA*  NA*   NA* 
*Data not yet available 
 
3.5 CAPS total severity scores  
The CAPS scores per PTSD symptom group and total symptom severity scores prior to and 
following NET of patients are given in Table 4. The CAPS total severity score of Patient 1 
decreased considerably from 90 initially to 63 following therapy. This involved large 
decreases, from 31 to 14 and from 33 to 18 for the symptom groups of re-experiencing and of 
increased arousal, respectively for this patient, during this period. Slight increases in 
avoidance symptoms were observed following therapy when compared to scores prior to 
treatment. However, avoidance scores decreased greatly, from 31 to 17, between the end of 
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therapy and the 3-month follow-up. Also the final total PTSD severity score for Patient 1 
reduced greatly between the end of treatment and the 3- month follow-up measurement, to a 
score of 49. The CAPS total severity score for Patient 2 had also decreased greatly from 105 
prior to therapy to 70 at the end of treatment (Table 4). This decrease incorporated a 
particularly large reduction in avoidance symptoms scores with a reduction from 41 to 18. 
Only a slight decrease, from 32 to 25, was observed for re-experiencing symptoms and no 
change was seen in increased arousal symptoms. Data for the 3-month follow-up are not yet 
available for Patient 2. 
 
Table 4. CAPS scores per PTSD symptom group and total severity scores prior to and 
following narrative exposure therapy (NET). 
 Patient 1 Patient 2 
 Before 
NET 
After 
NET 
3 mo 
follow-up 
Before 
NET 
After 
NET 
3 mo 
follow-up 
Re-experiencing 31 14 13 32 25 NA* 
Avoidance 26 31 17 41 18 NA* 
Increased arousal 33 18 19 32 32 NA* 
Total severity score 90 63 49 105 70 NA* 
*Data not yet available 
 
3.6 Exit questionnaire 
Patient 1 reported that she sleeps better (longer) following the therapy. She said that she also 
has her angry outbursts more under control and feels less guilty. She feels milder towards 
herself and others and her emotional regulation is better. She had little expectation of the 
therapy and found the exposure part of the therapy good. She was also very positive about the 
therapist. She found her really nice and understanding. She found the therapy too short since 
she had a lot of difficult life experiences and would like to have more NET and couples 
therapy.  
 
Patient 2 found that the therapy had an effect on her symptoms later in treatment. She felt 
recognised in being able to see how her life was and feels for a great part healed. She was 
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open and hopeful that the therapy would reduce her symptoms. She found the therapist good 
and the visual form of the therapy matched well with how she learns.  She would like to have 
follow-up therapy sessions with the same therapist on how to deal with similar situations. She 
would also like to have 3 or 4 more sessions possibly on how to deal with the death of her 
boyfriend.  
 
4. Discussion  
The efficacy of NET in the reduction of PTSD symptom scores and the increasing of QOL 
ratings in patients with PTSD arising from child abuse was investigated in this study. Overall, 
the results revealed somewhat conflicting findings. Much self-reported data of patients (used 
for visual plots, SPSS analysis and some of the reliable change index calculations) imply that 
little improvement in PTSD symptom scores and QOL ratings was obtained through NET. In 
contrast, RCIs from CAPS total severity symptoms scores suggest clinically significant 
reductions in PTSD symptom scores. 
 
4.1. Self-report data  
Although findings from self-reported data showed generally little change in PTSD symptom 
scores and QOL ratings, some significant changes from this data were also observed. The 
significant reduction in re-experiencing symptoms observed from SPSS analysis of PSS-SR 
data for Patient 2 was not supported by the CAPS scores. The significant reduction in 
avoidance symptoms for Patient 2 was observed from the SPSS analysis however, is greatly 
supported by the reduction of 23 observed for this PTSD criterion in the CAPS results at the 
end of therapy. Interestingly, with Patient 1 there was no decrease in avoidance symptoms 
from the baseline to at the end of the therapy; indeed a slight increase was observed. At the 3-
month follow-up, however, a large decrease in avoidance symptoms was also observed for 
Patient 1. The differences between patients in the PTSD symptoms groups where they 
experienced most improvement may be due to slight differences in focus of therapy by the 
therapists.The change in PTSD symptom scores observed using the PSS-SR for Patient 2 from 
prior to therapy to after the therapy was deemed clinically significant from the RCIs observed. 
However, since the PTSD symptom scores for this patient fluctuated greatly in the last few 
weeks of therapy, from 30 to 48, it is unlikely that this result is actually of clinical 
significance.   
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There are several possible explanations for the limited improvements observed for the rest of 
the self-reported data (PSS-SR scores and MANSA VN-12 data used for visual plots, SPSS 
mixed models analysis and the RCI calculations). Firstly, since these scores were filled in by 
patients themselves, they could, for several reasons (unintentionally or intentionally), have 
filled in scores indicating that they experienced less improvement in symptoms than they 
actually did. Some of these reasons include patients being negatively biased with respect to 
how they see themselves and their improvement. Indeed, both patients were also diagnosed 
with depressive episodes with the MINI during the baseline measurement phase of this 
research.  The cognitive model of depression proposes that the thinking of those suffering 
from depression is characterised by an emphasis on negative expectations and interpretations 
of one’s self, one’s future and the world (Beck, 2005). Furthermore, depressive thinking 
generally involves distortion and selection of negative interpretations, although positive 
explanations are equally likely. These errors in information processing occur automatically 
and spontaneously, outside the patient’s awareness (Hammen & Watkins, 2008) and could 
have played a role in the results obtained by self-report in this study.  
 
Patients may also have not wanted to appear better, so that the therapy could continue since 
both patients were positive about the therapy and their therapists and came loyally to their 
therapy sessions. In the exit questionnaire completed at the end of the treatment, both patients 
also indicated that they would like to have had more therapy. Besides, patients could have 
quickly and also inaccurately filled in the questionnaires since their usually requiring 
reminders to fill them in suggested some difficulty/confrontation with their PTSD symptoms 
in doing so. A second reason for the absence of significant results from self-reported 
questionnaires may be due to the questionnaires used having a low sensitivity to changes due 
to treatment. Maric et. al (2015) proposed the need to use instruments specifically designed 
for the regular assessment of clinical symptoms or whose psychometric properties with 
respect to sensitivity to therapeutic change are sufficient. These authors report that non-
significant changes can be incorrectly concluded from questionnaires not meeting these 
standards. However, in a study assessing the influence of a brief psychotherapeutic 
intervention on factors concerning QOL, Petrakis and Joubert (2013) reported significant 
improvements using the MANSA questionnaire. Also the PSS-SR is frequently used as an 
instrument to measure PTSD symptom scores in therapy research. E.g., van den Berg (2015) 
found large decreases in PTSD symptoms from 30 to 16 with the PSS-SR in an RCT 
comparing the efficacy of prolonged exposure, EMDR and remaining on a waiting list for the 
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treatment of patients with PTSD and a psychotic disorder. Thus, it seems unlikely that a low 
sensitivity to changes due to treatment of the questionnaires employed in this study is a 
plausible explanation for the non-significance of some of the self-reported results. 
 
4.2 Clinical interview data 
The decrease in the CAPS total severity score for Patient 1 from 90 prior to treatment to 63 
following treatment implies, according to Hovens et al. (2005), that the PTSD diagnosis of 
Patient 1 changed from severe PTSD to moderate PTSD. This finding is supported by the 
clinically significant absolute RCI values obtained for Patient 1 for the changes in PTSD 
symptom scores during this period. Also, importantly the large further reduction to 49 for the 
CAPS score at the 3-month follow-up is just a few scores above a classification of mild or no 
PTSD, which according to Hovens et al. (2005) ranges from 45-65. These reductions in CAPS 
total severity score are also supported by the apparent clinical significance of these scores as 
determined by the RCI values. The reduction in the CAPS total severity score of 35 points to 
70 for Patient 2 was similar to that observed for Patient 1 following therapy. The decrease 
seen for Patient 2 however, did not allow the diagnosis of severe PTSD for this patient to be 
reduced to one of lower severity although it was deemed clinically significant by the RCI 
values. The clinical significance of our CAPS reductions of 27 and 41 for Patient 1 after 
therapy and at the 3-month follow-up, respectively, and of 35 for Patient 2 after the therapy is 
agreement with findings of other authors. Weathers et al. (2001) and Erbes et al. (2014) 
proposed that reductions in CAPS total severity score of 10-12 or 15 points, respectively, are 
clinically significant. The clinically significant reduction in CAPS scores for both patients 
appear to be supported by the responses to the questions in the exit questionnaire. Patient 1 
reported that she slept better, has greater regulation of her anger, feels less guilty and feels 
milder towards herself. Patient 2 reported that she felt “for a great part healed”.  Furthermore, 
both patients were positive about their therapists. It is widely accepted that positive 
therapeutic alliances are associated with better therapeutic outcomes (Martin et al., 2000).   
 
Reductions in CAPS results observed for NET in this study were also found by previous 
authors. In a study of refugees with PTSD arising from experiencing war and torture, Morath  
et al. (2014) also reported clinically significant decreases in CAPS scores after 12 sessions of 
NET. An average CAPS score of 92 prior to therapy was reduced to 55 at the 4-month follow-
up and further to 43 at the 1-year follow-up. Also, in an RCT comparing the efficacy of NET 
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and interpersonal psychotherapy for the treatment of PTSD in Rwandan genocide orphans, 
Schaal et al. (2009) reported moderate decreases in CAPS scores from 67 prior to therapy to 
50 the end of therapy with NET. Furthermore, in a systematic review and meta-analysis on the 
psychological treatments for severe PTSD in adults, Cusack et al. (2016) reported moderate 
evidence for NET in the reduction of PTSD symptoms. The evidence for NET regarding the 
loss of a diagnosis of PTSD however was low in this study. The extent of the reduction in 
CAPS scores observed in this study may have been attributable to the likelihood that NET 
encompasses all three recent psychological theories of PTSD as discussed earlier in this 
thesis. 
 
4.3 Comparison of the findings from the clinical interview and the self-report data 
Several explanations exist for the discrepancy in the reduction in the PTSD symptom scores 
seen with the CAPS and the PSS-SR observed in this study.  Firstly, since the CAPS involves 
a much more detailed assessment of the individual PTSD symptom scores than the PSS-SR, 
involving the judgement of the frequency and intensity of the symptoms as well as requiring 
examples,  it is likely that more accurate results are achieved with the CAPS. Even the authors 
of the PSS-SR (Foa et al., 1993) propose that although the PSS-SR can be used as a measure 
of PTSD symptom severity, that this instrument should be “an adjunct to a clinical interview 
with traumatized individuals”. Hereby, they acknowledge the superiority of the clinical 
interview over the PSS-SR for the diagnosis of PTSD. Also, in an RCT treating patients with 
PTSD and psychotic disorders, Van den Berg et al. (2015) used the CAPS total symptom 
severity score as the primary outcome measure of PTSD symptoms and scores from the PSS-
SR as a secondary measure. 
 
Also, it likely that therapists view therapy outcomes more favourably than patients themselves 
since, as outlined previously, patients may have a negative view of their functioning. For 
example, it can be that as some symptoms decreased, patients became more aware of other 
symptoms. A psychologist may correctly see such a change as an improvement in functioning, 
whereas patients themselves may not see it as progress, but as just another difficulty arising. 
However, in contrast to our findings, in their RCT treating patients with PTSD and psychotic 
disorders, Van den Berg et al. (2015) reported that self-reported PTSD symptoms observed 
with the PSS-SR showed similar reductions in PTSD symptoms as the CAPS results. In the 
present study, the psychologist may also have been somewhat biased in his rating during the 
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CAPS interview since he was also aware that the patients were taking part in a research study. 
Experimenter expectancy effects, defined by Kazdin (2010) as beliefs and desires of the 
experimenter about the performance of the patients and about the outcomes may thus have 
played a role in the results and particularly the CAPS results in this study. It is import 
therefore to measure the inter rater-reliability for this clinical interview. 
 
4.4 Improvements in symptoms during the 3-month follow-up 
The further large reduction in the CAPS scores as well as the slight reduction in PSS-SR 
scores and the increase in the MANSA VN-12 scores for Patient 1 between the end of therapy 
and the 3-month follow-up is frequently observed with NET. According to Jongedijk (2014), 
the full effects of NET are not evident directly after the end of therapy, and may only be seen 
at least 6 months afterwards. These improvements after the end of therapy refer not only to 
reductions in PTSD symptoms, but also to other symptoms such as those of depression. 
Furthermore, several other authors have reported decreases in PTSD symptoms between the 
end of NET and follow-up measurements after 3-6 months. Firstly in a study on the 
comparison of the efficacy of NET to that of other forms of counselling in the treatment of 
traumatised African refugees Neuner et al. (2004) reported further deceases in PTSD 
symptoms up to 1 year. Also, in a pilot randomised controlled feasibility study of NET for the 
treatment of PTSD in Chinese earthquake survivors, Zang et al. (2014) found that reductions 
observed in PTSD symptoms continued during the 3-month follow-up. 
   
One possible reason for this further decrease in PTSD symptom scores frequently experienced 
by NET patients may be as follows. Since NET deals with all patients major life events in a 
relatively short period, it may take more time for patients to really process these events and 
the usually great impact they have on their lives. 
 
4.5 The importance of the results of this study 
Although the efficacy of NET for the treatment of PTSD in refugees and veterans and 
orphans, who have experience multiple traumas, has been determined, this is to the author’s 
knowledge, one of the first studies to investigate the efficacy of NET in patients with PTSD 
arising from child abuse. The two other known studies, Pabst,et al. (2012) and Dōmen et al., 
2012 ( as cited in Jongedijk, 2014) are discussed in the introduction. Briefly, in the first study 
the patients also had borderline personality disorders which may have interfered with the 
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therapeutic relationship and the second study was published in Japanese which makes the 
quality difficult to determine. Also both studies had low numbers of patients.  This makes the 
findings of the present study of special interest. In this study 16 sessions of NET were 
sufficient to obtain clinically significant reductions observed with the CAPS for both patients. 
Although less positive findings were observed with the self-report data, it appears, at least 
from these preliminary results, that NET can be seen as an effective treatment for this patient 
group. More data is needed however, to confirm these findings. If proven effective, the 
existence of NET would increase the number of therapies available to patients with PTSD 
providing them with greater choice. The existence of a milder PTSD treatment than traditional 
exposure therapy exposure is desirable and patients may experience NET as milder since it 
also involves a narrative element. Indeed, drop-out observed from several studies on NET is 
low (Jongedijk, 2014). It is also probably partly due to this reason that it is a preferred PTSD 
treatment among therapists (Jongedijk, 2014). Low drop-out could also mean that more 
patients, often desperately needing treatment, could avail of it. Furthermore, in the exit 
questionnaire, used in this study, patients revealed that NET had effects in other ways besides 
on the PTSD symptoms. These included feeling less guilty, being milder towards one’s self 
and others and having better emotional regulation all of which may be valuable in improving 
a patient’s QOL. The fact that trauma processing in NET takes the context of the trauma and 
the patient’s whole life history into account (Jongedijk, 2014) may account for these added 
effects. E.g., Timmers (2015) suggests that the reduction in the feelings of guilt of the patient 
may have been brought about by recognition from the therapist for the abusive manner in 
which the patient was treated.  
 
The exclusion of a third patient in this study (for which data is not included) provided us with 
valuable information on the generalizability of NET. This patient was excluded since he had 
much difficulty with emotion regulation and regularly reported that he felt suicidal after NET 
sessions. It is likely that this patient had a more complex form of PTSD since, according to 
Herman (1992) and Ford (2015) emotion regulation is one of the domains in which patients 
with child-abuse related “complex PTSD” have difficulty with over patients with simple 
PTSD. The inability of this patient to withstand the emotions brought up by NET indicates 
that this form of therapy is unsuitable for the treatment for patients with limited emotional 
regulation. This is in line with findings of others (Levitt & Cloitre, 2006; Dorrepaal et al., 
2014) who suggest that patients with PTSD from child abuse and those with difficulties in 
emotion-regulation are at risk for dropout from therapy and worsening of symptoms. 
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However, the requirement of reasonable emotion regulation in patients also holds for other 
PTSD treatments since the ability to regulate emotions, and particularly anxiety, is necessary 
for the processing of trauma-related anxiety. Also, concerning the generalizability of NET, 
although the two patients were of different nationalities and cultures, similar results were 
obtained. The number of patients, however, is too small to draw definite conclusions on the 
generalizability of NET for this patient group with respect to nationalities and cultures. 
 
4.6 Limitations and future research  
Some limitations of this work deserve comment. On some occasions, when patients did not 
fill in the questionnaires after repeated reminders, therapists asked patients to fill in the 
questionnaires. This revealed to the patients that the therapists were also, at least indirectly, 
involved with the research and this may have somewhat influenced the patients’ answers. To 
avoid this it would have been desirable that all matters concerning the research be carried out 
by the researchers. Also the NET protocol used by the therapists was not controlled (therapy 
adherence) with their first patients in this study. This is desirable so that all patients receive 
the therapy according to the official NET protocol. However, this will be carried out for both 
therapists later on in this study. Although it is known that the full effects of NET can often 
only be seen 6 months after the end of therapy (Jongedijk, 2014), no 6-month follow-up data 
were obtained for Patient 1 due to illness of the patient around this time. A further possible 
limitation is that the study was not blinded. Thus experimenter expectancy effects, as outlined 
above in section 4.3, may have played a role in the results obtained. Such expectancies can 
adversely influence the construct validity of the study (Kazdin, 2010). The inter-rater 
reliability was also not determined for the CAPS in this study but will be carried out at a later 
stage.  Finally, the intervals between the filing-in of questionnaires during the baseline phases 
were much lower (2 days) that for the treatment phases (6 days). There were several reasons 
for choosing to decrease of the interval in the baseline phase. Most importantly it was 
assumed a patient’s mood can vary sufficiently over a 48-hr period, and particularly when 5 
measurements were taken, to allow the desired realistic variation in the baseline 
measurements to be included. Indeed, it was noted that for one patient’s scores for the PSS-
SR varied between 27 and 19 over a 48-hr period.  Also patients were keen to begin with the 
therapy as soon as possible and in order to provide this, the baseline phase was kept to a 
minimum.  
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Given the seriousness of the effects of child abuse on the mental health of the victims, more 
research on treatments for PTSD in these patients is of great importance. Specifically, further 
studies determining the efficacy of NET on the treatment of child abuse-related PTSD are 
clearly needed. In such studies it would also be useful to the measure symptoms in the three 
areas besides PTSD symptoms in which these patients are believed to have difficulty, namely 
their (negative) self-concept, in the processing of emotions and in relationships.  If findings 
from such studies are still positive, an RCT could be carried out comparing NET with 
prolonged exposure for treatment efficacy, drop-out and the effect on other general factors 
such as kindness towards one’s self. Future research with NET could also further explore the 
mechanisms by which NET is effective. 
 
5. Conclusions 
Findings on the efficacy of NET for the treatment of PTSD arising from childhood abuse from 
the patients in this study were somewhat equivocal. Self-report data for total PTSD symptoms 
and QOL ratings indicate little improvement with NET. However, when data was divided into 
PTSD symptoms groups, significant changes in re-experiencing and avoidance were 
observed. RCIS from CAPS data also suggest that NET produced clinically significant 
reductions in PTSD symptom scores for both patients and that reductions were even greater 3 
months following therapy. This preliminary data indicates thus that NET is effective for the 
treatment of child-abuse related PTSD. However, results from a greater number of patients of 
this group are needed to more definitely determine the efficacy of NET.   
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Appendix 1 
Calculation of the Reliable Change Index (RCI; Jacobson and Truax, 1991) 
 
 
 RCI =
DiffS
XX 12 
  2X = post therapy score from the relevant questionnaire 
   1X  = pre-therapy score (average of baseline scores) from 
the relevant questionnaire 
  
 DiffS  =
2)(2 ES  
 
  
ES  = S1 xxr1         xxr  = test-retest reliability of the relevant questionnaire  
S1 = pre-test standard deviation from the relevant 
population  
 
Table 5. Test-retest reliability values and pre-test standard deviations from the psychiatric 
population for the PSS-SR, the MANSA VN-12 and the CAPS instruments. 
a
from Weathers et al. (1999) 
b
from Foa et al. (1997) 
c
from Van Nieuwenhuizen et al. (2015) 
d
average of 14.2 ( Morath et al., 2014) and 16.2 (Van den Berg et al., 2015) 
 
 
Table 6. Pre-test (prior to therapy), post-test (after therapy) and 3-month follow-up PSS-
SR PTSD symptom scores and MANSA VN-12 quality of life (QOL) scores 
 PSS-SR PTSD 
Symptoms score 
MANSA VN-12          
QOL ratings 
CAPS total severity       
scores 
 Pre-test Post-test Pre-test Post-test Pre-test Post-test 
Patient 1       
-Start/end of Therapy 38.0 40.0 31.0 29.0 90 63 
-3 mo follow-up - 32.0 - 33.0 - 49 
       
Patient 2       
- Start/end of Therapy 44.6 30.0 40.8 46.0 105 70 
-3 mo follow-up - NA* - NA* - NA* 
*Data not yet available 
 
 
 Test-retest reliability Pre-test standard deviation of score 
from the psychiatric population  
PSS-SR 0.74 9.96
b
  
MANSA VN-12 0.74 5.27
c
 
CAPS    0.63
a
 15.2
d
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Appendix 2 
 Dutch version of the PTSD Symptom Scale-Self-Report (PSS-SR)  
 
PDS:         Naam: ___________                            Datum: ______________ 
 
 
Onderstaand volgt een lijst van problemen waar mensen soms 
mee te maken krijgen na een traumatische gebeurtenis. Lees 
deze zorgvuldig door en omcirkel het cijfer (0 – 3) dat het best 
aangeeft in hoeverre dit bepaalde probleem u bezig hield/houdt 
gedurende de afgelopen week. 
 
0       Nooit 
1       1 keer per week of minder/ eens in de zoveel tijd 
2       2 - 4 keer per week/ de helft van de tijd 
3       bijna de hele tijd 
 
 
1.  Pijnlijke gedachten of beelden over de      0  1  2  3 
     traumatische gebeurtenis, terwijl u er niet  
 aan wilde denken 
 
2.  Onprettige dromen of nachtmerries over de        0  1  2  3 
     traumatische gebeurtenis 
 
3.  De ervaring alsof de traumatische gebeurtenis    0  1  2  3 
  weer plaats vindt, dat u handelt of het voelt  
 alsof het weer gebeurt 
 
4.  Emotioneel overstuur raken bij het herinnerd     0  1  2  3 
     worden aan de traumatische gebeurtenis (b.v. 
 gevoelens van angst, kwaadheid, bedroefdheid,  
 schuldgevoelens)  
      
5.  Lichamelijke reacties ervaren wanneer u aan de 0  1  2  3 
     traumatische gebeurtenis herinnerd wordt  
 (b.v. in zweet uitbreken, hartkloppingen krijgen) 
     
6.  Proberen niet aan de traumatische gebeurtenis    0  1  2  3 
 te denken, er niet over te spreken, of om de  
 gevoelens erover te vermijden 
 
7.  Proberen activiteiten, mensen, of plaatsen te       0  1  2  3 
     vermijden die aan de traumatische gebeurtenis  
 doen herinneren 
 
8.  Niet in staat zijn een belangrijk deel van de        0  1  2  3 
     traumatische gebeurtenis te herinneren 
 
9.  Aanzienlijk minder interesse voor, of deelname 0  1  2  3 
     aan voor u belangrijke activiteiten 
     
10. Het gevoel hebben mensen in uw omgeving op  0  1  2  3 
 een afstand of afgesneden van u te ervaren 
 
11.Gevoelloosheid, zoals niet kunnen huilen,   0  1  2  3 
     geen liefde kunnen voelen  
     
12. Gevoel dat uw toekomstplannen de grond                0  1  2  3 
      in geboord zijn, dat er geen hoop meer is 
      (b.v. voor het maken van carrière, een  
      gelukkige relatie hebben, (klein)kinderen  
      hebben, of een lang leven leiden) 
        
13. Problemen met inslapen of doorslapen                   0  1  2  3 
 
14. Last van snel geïrriteerd zijn of van                          0  1  2  3 
      woede-uitbarstingen 
 
15. Moeilijkheden met concentreren, zoals de                0  1  2  3 
      draad kwijt raken tijdens een gesprek, de 
      t.v. niet kunnen volgen, niet meer weten  
      wat u zojuist gelezen heeft   
  
16. Erg waakzaam of op uw hoede zijn (b.v.                  0  1  2  3 
      controleren wie er zich achter u bevindt, 
      ongemakkelijk gevoel als u zich met uw rug 
  naar een deur bevindt, etc.) 
       
17. Schrikachtig, gespannen zijn (b.v. als                       0  1  2  3 
      iemand achter u loopt) 
      
 
 
 
Geef aan in hoeverre de problemen die u in het voorgaande 
aankruiste u hinderden op één of meer van de volgende 
levensgebieden gedurende de afgelopen maand. Omcirkel ‘ja’ of 
‘nee’. 
 
1.   Werk                       Ja  Nee 
2.   Huishoudelijke werkzaamheden     Ja  Nee 
 en plichten      
3.   Vriendschapsrelaties      Ja   Nee                
4.   Vrijetijdsbesteding, uitgaan              Ja   Nee  
5.   Studie                         Ja   Nee        
6.   Relaties met uw familieleden           Ja   Nee.        
7.   Seksueel leven        Ja   Nee 
8.   Algemene voldoening in het leven   Ja    Nee 
9.   Algemeen functioneren op alle       Ja    Nee 
      levensterreinen     
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Appendix 3 
The Manchester verkorte Kwaliteit van Leven meting (MANSA VN-12) 
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Appendix 4  
Dutch version of the Childhood Trauma Questionnaire–Short Form (CTQ–SF) 
 
De onderstaande stellingen gaan over ervaringen gedurende uw kinder- en tienerjaren. Omcirkel steeds 
het antwoord dat het best bij u past. Hoewel sommige vragen persoonlijk zijn, willen we u toch 
verzoeken om alle vragen zo eerlijk mogelijk te beantwoorden. Uw antwoorden zullen vertrouwelijk 
worden behandeld. 
 TIJDENS MIJN JEUGD …… nooit 
waar 
zelden 
waar 
soms 
waar 
vaak 
waar 
zeer 
vaak 
waar 
1 had ik niet voldoende te eten 1 2 3 4 5 
2 wist ik dat er iemand was om voor me te zorgen en me te 
beschermen 
 
1 
 
2 
 
3 
 
4 
 
5 
3 noemden mensen in mijn gezin mij dingen als “dom”, “lui” 
of “lelijk” 
 
1 
 
2 
 
3 
 
4 
 
5 
4 waren mijn ouders te dronken of stoned (onder invloed van 
drugs) om voor het gezin te zorgen 
 
1 
 
2 
 
3 
 
4 
 
5 
5 was er iemand in mijn gezin die me het gevoel gaf dat ik 
belangrijk en bijzonder was 
 
1 
 
2 
 
3 
 
4 
 
5 
6 moest ik vieze kleren dragen 1 2 3 4 5 
7 had ik het gevoel dat er van me gehouden werd 1 2 3 4 5 
8 had ik het gevoel dat mijn ouders wensten dat ik nooit 
geboren was 
 
1 
 
2 
 
3 
 
4 
 
5 
9 ben ik door iemand uit mijn gezin zo hard geslagen dat ik 
naar een dokter of naar het ziekenhuis moest gaan 
 
1 
 
2 
 
3 
 
4 
 
5 
10 was er niets dat ik wilde veranderen aan mijn gezin 1      2 3 4 5 
11 ben ik zo hard geslagen door mensen in mijn gezin dat ik er 
blauwe plekken of littekens aan overhield 
 
1 
 
2 
 
3 
 
4 
 
5 
12 ben ik gestraft met een riem, een plank, een touw, of een 
ander hard voorwerp 
 
1 
 
2 
 
3 
 
4 
 
5 
13 kwamen mijn gezinsleden voor elkaar op 1 2 3 4 5 
14 zeiden mensen in mijn gezin kwetsende of beledigende 
dingen tegen me 
 
1 
 
2 
 
3 
 
4 
 
5 
15 geloof ik lichamelijk mishandeld te zijn geweest 1 2 3 4 5 
16 had ik de perfecte jeugd 1 2 3 4 5 
17 ben ik zo hard geslagen dat het opgemerkt werd door iemand 
zoals een leraar, een van de buren, of een dokter 
 
1 
 
2 
 
3 
 
4 
 
5 
18 had ik het gevoel dat iemand in mijn gezin me haatte 1 2 3 4 5 
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 TIJDENS MIJN JEUGD …… nooit 
waar 
zelden 
waar 
soms 
waar 
vaak 
waar 
zeer 
vaak 
waar 
21 dreigde iemand me pijn te doen of leugens over me te 
vertellen als ik niet iets seksueels met hem of haar deed 
 
1 
 
2 
 
3 
 
4 
 
5 
22 groeide ik op in het best denkbare gezin 1 2 3 4 5 
23 wilde iemand mij seksuele dingen laten doen of naar 
seksuele dingen laten kijken 
 
1 
 
2 
 
3 
 
4 
 
5 
24 ben ik door iemand gemolesteerd 1 2 3 4 5 
25 geloof ik emotioneel mishandeld te zijn geweest 1 2 3 4 5 
26 was er iemand die me naar de dokter bracht als dat nodig 
was 
 
1 
 
2 
 
3 
 
4 
 
5 
27 geloof ik seksueel misbruikt te zijn geweest 1 2 3 4 5 
28 was mijn gezin een bron van kracht en ondersteuning 1 2 3 4 5 
 
 
 
Wat is uw leeftijd? ………. jaar 
 
Wat is uw geslacht? M / V 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 voelden de leden van mijn gezin zich met elkaar verbonden 1 2 3 4 5 
20 probeerde iemand mij op een seksuele manier te betasten, of 
mij ertoe te brengen hem of haar te betasten 
 
1 
 
2 
 
3 
 
4 
 
5 
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Appendix 5 
Exit questionnaire  
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